How to buy Immunodiagnostic Systems Holdings shares | 211.3p

Own Immunodiagnostic Systems Holdings shares in just a few minutes.


Fact checked

Immunodiagnostic Systems Holdings PLC is a medical devices business based in the UK. Immunodiagnostic Systems Holdings shares (IDH.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 211.3p – a decrease of 6.09% over the previous week. Immunodiagnostic Systems Holdings employs 276 staff and has a trailing 12-month revenue of around £34.3 million.

How to buy shares in Immunodiagnostic Systems Holdings

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: IDH in this case.
  5. Research Immunodiagnostic Systems Holdings shares. The platform should provide the latest information available.
  6. Buy your Immunodiagnostic Systems Holdings shares. It's that simple.
The whole process can take as little as 15 minutes.

How has Coronavirus impacted Immunodiagnostic Systems Holdings's share price?

Since the stock market crash in March caused by coronavirus, Immunodiagnostic Systems Holdings's share price has had significant negative movement.

Its last market close was 211.3p, which is 4.39% down on its pre-crash value of 221p and 32.06% up on the lowest point reached during the March crash when the shares fell as low as 160p.

If you had bought £1,000 worth of Immunodiagnostic Systems Holdings shares at the start of February 2020, those shares would have been worth £829.26 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,030.72.

Immunodiagnostic Systems Holdings share price

Use our graph to track the performance of IDH stocks over time.

Immunodiagnostic Systems Holdings shares at a glance

Information last updated 2020-12-26.
Latest market close211.3p
52-week range158.7064p - 307.4936p
50-day moving average 211.2857p
200-day moving average 231.3357p
Wall St. target price268.59p
PE ratio 161.5385
Dividend yield 0.02p (0.9%)
Earnings per share (TTM) 1.3p
eToro Free Stocks

Invest in Immunodiagnostic Systems Holdings shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Zero platform fee
Your first 100 trades are free with Fineco, T&Cs apply.
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Hargreaves Lansdown Fund and Share Account
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
Degiro Share Dealing
£1.75 + 0.022% (max £5.00)
£1.75 + 0.022% (max £5.00)
Portfolio transfer fees (in & out)
Degiro is widely seen as one of the best low-cost share brokers, for people who are looking to trade regularly. Capital at risk.

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Hargreaves Lansdown stocks and shares ISA
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Nutmeg stocks and shares ISA
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
Moneyfarm stocks and shares ISA
Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Legal & General stocks and shares ISA
Legal & General stocks and shares ISA
£100 or £20 a month
Legal & General is a big financial services company which offers insurance, lifetime mortgage, pensions and stocks and shares ISAs. Capital at risk.

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Moneyfarm Pension
£1,500 (initial investment)
7 funds
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
AJ Bell Pension
Over 2,000 funds
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
No minimum
4 portfolios
Moneybox Pension
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Immunodiagnostic Systems Holdings stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Immunodiagnostic Systems Holdings price performance over time

Historical closes compared with the last close of 210p

1 week (2021-01-08) -1.87%
1 month (2020-12-18) -2.33%
3 months (2020-10-16) -12.50%
6 months (2020-07-17) -10.64%
1 year (2020-01-17) -19.23%
2 years (2019-01-17) 12.00%
3 years (2018-01-17) -27.59%
5 years (2016-01-15) -7.39%

Is Immunodiagnostic Systems Holdings under- or over-valued?

Valuing Immunodiagnostic Systems Holdings stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Immunodiagnostic Systems Holdings's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Immunodiagnostic Systems Holdings's P/E ratio

Immunodiagnostic Systems Holdings's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 162x. In other words, Immunodiagnostic Systems Holdings shares trade at around 162x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Immunodiagnostic Systems Holdings's EBITDA

Immunodiagnostic Systems Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £3.2 million.

The EBITDA is a measure of a Immunodiagnostic Systems Holdings's overall financial performance and is widely used to measure a its profitability.

Immunodiagnostic Systems Holdings financials

Revenue TTM £34.3 million
Gross profit TTM £17.4 million
Return on assets TTM -2.11%
Return on equity TTM 0.69%
Profit margin 1.11%
Book value 1.876p
Market capitalisation £60.4 million

TTM: trailing 12 months

Immunodiagnostic Systems Holdings share dividends

Dividend payout ratio: 9500% of net profits

Recently Immunodiagnostic Systems Holdings has paid out, on average, around 9500% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.9% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Immunodiagnostic Systems Holdings shareholders could enjoy a 0.9% return on their shares, in the form of dividend payments. In Immunodiagnostic Systems Holdings's case, that would currently equate to about 0.02p per share.

Immunodiagnostic Systems Holdings's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 16 July 2020 (the "ex-dividend date").

Immunodiagnostic Systems Holdings share price volatility

Over the last 12 months, Immunodiagnostic Systems Holdings's shares have ranged in value from as little as 158.7064p up to 307.4936p. A popular way to gauge a stock's volatility is its "beta".

IDH.LSE volatility(beta: 0.8)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Immunodiagnostic Systems Holdings's is 0.8. This would suggest that Immunodiagnostic Systems Holdings's shares are less volatile than average (for this exchange).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Immunodiagnostic Systems Holdings overview

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site